Pre-made Licaminlimab benchmark antibody ( scFv, anti-TNFA/TNF therapeutic antibody, Anti-DIF/TNFSF2/TNLG1F Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-310

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-310 Category Tag

Product Details

Pre-Made Licaminlimab biosimilar, scFv, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Licaminlimab biosimilar, scFv, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody

INN Name

Licaminlimab

Target

TNF

Format

scFv

Derivation

NA

Species Reactivity

Human

CH1 Isotype

NA

VD LC

Lambda

Highest_Clin_Trial (Jan '20)

Phase-II

Est. Status

Active

100% SI Structure

None

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2020

Companies

Oculis

Conditions Approved

NA

Conditions Active

Dry eye syndrome

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

TNFA

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide